不寻常的左心房质量:一个患有血瘤的患者的诊断和手术见解
Mohannad Dawary1, Sultan Askar2, Osama Khalil3
1Department of Cardiac Surgery, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
JACC. Case reports
|September 9, 2025
概括
心脏血管瘤是一种罕见的血管瘤. 心声谱有助于诊断,而手术切除是这些罕见的心脏瘤的唯一确定的治疗方法.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
背景情况:
- 心脏瘤很少见,大多数是良性的.
- 血管性心脏瘤,包括血管瘤,占所有心脏瘤的1-2%.
研究的目的:
- 为了呈现心脏血管瘤病例.
- 为突出心脏血管瘤的诊断和治疗策略.
主要方法:
- 一名53岁的妇女出现心和呼吸短促.
- 心声扫描发现左心房质量,最初怀疑是肌瘤.
- 经过手术切除,随后进行了组织病理学检查,证实了心脏血管瘤的诊断.
主要成果:
- 组织病理学证实左心房质量是心脏血管瘤.
- 心脏血管瘤通常无症状,可以被误诊为myxomas.
结论:
- 心脏血管瘤非常罕见,需要高的怀疑指数才能诊断.
- 心声成像是首选的成像方式.
- 手术切除仍然是心脏血管瘤的唯一确定的治疗方法.
相关概念视频
Mitral Stenosis II: Clinical features and Diagnostic Tests
223
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
223
Cardiac Catheterization III: Left Heart Catheterization
597
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
597
Cardiomyopathy III: Hypertrophic Cardiomyopathy
416
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416


